Menu

Kevin Cooper

Partner

kcooper@cooley.com

full contact info

Kevin focuses on mergers and acquisitions and other complex corporate transactions, representing public and private companies in their most important strategic matters. His practice also includes advising clients with respect to shareholder activism, corporate governance and takeover defense. He advises clients in a wide range of industries, including technology, life sciences, consumer, entertainment, fintech, financial services, and private equity.

Download full bio 

Experience

  • Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion 

  • SPAC BowX Agrees to $9 Billion Merger With WeWork 

  • Truebill Agrees to Sell to Rocket Companies for $1.275 Billion 

  • Intersect ENT Agrees to Sell to Medtronic for More Than $1 Billion 

  • Clarabridge Agrees to Sell to Qualtrics for $1.125 Billion 

  • View all

Practices & Industries
Education

  • Harvard Law School
    JD, magna cum laude
    Joshua Montgomery Sears, Jr. Prize; founder and editor-in-chief of the Harvard Business Law Review

  • California State University - Fresno
    MBA, with distinction

  • California State University - Fresno
    BS, Finance
    summa cum laude

Admissions & Credentials

New York

Media & Insight

Recent Blog Postings

Renegotiating Deal Terms? Delaware Reminds Fiduciaries of Unremitting Duties

Social Distancing From a (Supposed) Life Partner: Early Lessons From Deals Terminated and On the Rocks in the COVID-19 Era

Long-Term Focus: Preparing for Activism + Takeovers Amid COVID-19 Risks

Cooley’s 2019 Tech M&A Year in Review

Cooley's 2019 Life Sciences M&A Year in Review

Taking a Play out of the Financial Acquirer’s Playbook

Use of Earn-Outs to “Bridge” the Valuation Gap

 

 

Contact

kcooper@cooley.com

+1 212 479 6030

Locations